106 related articles for article (PubMed ID: 28762267)
1. Charge-Reversible Multifunctional HPMA Copolymers for Mitochondrial Targeting.
Wang F; Sun W; Li L; Li L; Liu Y; Zhang ZR; Huang Y
ACS Appl Mater Interfaces; 2017 Aug; 9(33):27563-27574. PubMed ID: 28762267
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting.
Li L; Yang Q; Zhou Z; Zhong J; Huang Y
Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960
[TBL] [Abstract][Full Text] [Related]
3. Improved mitochondrial targeting effect of HPMA copolymer by SS20 peptide mediation and nonendocytosis pathway.
Liu Y; Li Q; Xiong X; Zhou Z
J Pept Sci; 2019 Feb; 25(2):e3144. PubMed ID: 30588703
[TBL] [Abstract][Full Text] [Related]
4. Enhanced intracellular and intranuclear drug delivery mediated by biomimetic peptide SVS-1 for anticancer therapy.
Xiang Y; Chen L; Zhou R; Huang Y
Int J Pharm; 2019 Oct; 570():118668. PubMed ID: 31494237
[TBL] [Abstract][Full Text] [Related]
5. Synergistic enhancement of anticancer therapeutic efficacy of HPMA copolymer doxorubicin conjugates via combination of ligand modification and stimuli-response srategies.
Li L; Zhou M; Huang Y
Int J Pharm; 2018 Jan; 536(1):450-458. PubMed ID: 29237570
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeting and cell-penetrating peptides-co-modified HPMA copolymers for enhancing therapeutic efficacy of α-tocopheryl succinate.
Liu Y; Li Q; Xiong X; Huang Y; Zhou Z
J Mater Chem B; 2018 Dec; 6(46):7674-7683. PubMed ID: 32254889
[TBL] [Abstract][Full Text] [Related]
7. Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates.
Yang Y; Zhou Z; He S; Fan T; Jin Y; Zhu X; Chen C; Zhang ZR; Huang Y
Biomaterials; 2012 Mar; 33(7):2260-71. PubMed ID: 22189143
[TBL] [Abstract][Full Text] [Related]
8. Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers.
Lammers T; Kühnlein R; Kissel M; Subr V; Etrych T; Pola R; Pechar M; Ulbrich K; Storm G; Huber P; Peschke P
J Control Release; 2005 Dec; 110(1):103-18. PubMed ID: 16274831
[TBL] [Abstract][Full Text] [Related]
9. A novel mitochondrial targeted hybrid peptide modified HPMA copolymers for breast cancer metastasis suppression.
Li Q; Yang J; Chen C; Lin X; Zhou M; Zhou Z; Huang Y
J Control Release; 2020 Sep; 325():38-51. PubMed ID: 32598957
[TBL] [Abstract][Full Text] [Related]
10. Influence of histidine incorporation on buffer capacity and gene transfection efficiency of HPMA-co-oligolysine brush polymers.
Shi J; Schellinger JG; Johnson RN; Choi JL; Chou B; Anghel EL; Pun SH
Biomacromolecules; 2013 Jun; 14(6):1961-70. PubMed ID: 23641942
[TBL] [Abstract][Full Text] [Related]
11. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
[TBL] [Abstract][Full Text] [Related]
12. A pH-responsive sequential-disassembly nanohybrid for mitochondrial targeting.
Li L; Sun W; Li L; Liu Y; Wu L; Wang F; Zhou Z; Zhang Z; Huang Y
Nanoscale; 2017 Jan; 9(1):314-325. PubMed ID: 27910990
[TBL] [Abstract][Full Text] [Related]
13. Endocytotic uptake of HPMA-based polymers by different cancer cells: impact of extracellular acidosis and hypoxia.
Gündel D; Allmeroth M; Reime S; Zentel R; Thews O
Int J Nanomedicine; 2017; 12():5571-5584. PubMed ID: 28831253
[TBL] [Abstract][Full Text] [Related]
14. Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles.
Zhou Z; Li L; Yang Y; Xu X; Huang Y
Biomaterials; 2014 Aug; 35(24):6622-35. PubMed ID: 24814427
[TBL] [Abstract][Full Text] [Related]
15. Comparison of active and passive targeting of doxorubicin for somatostatin receptor 2 positive tumor models by octreotide-modified HPMA copolymer-doxorubicin conjugates.
He S; Zhou Z; Li L; Yang Q; Yang Y; Guan S; Zhang J; Zhu X; Jin Y; Huang Y
Drug Deliv; 2016; 23(1):285-96. PubMed ID: 24865288
[TBL] [Abstract][Full Text] [Related]
16. P(HPMA)-block-P(LA) copolymers in paclitaxel formulations: polylactide stereochemistry controls micellization, cellular uptake kinetics, intracellular localization and drug efficiency.
Barz M; Armiñán A; Canal F; Wolf F; Koynov K; Frey H; Zentel R; Vicent MJ
J Control Release; 2012 Oct; 163(1):63-74. PubMed ID: 22613881
[TBL] [Abstract][Full Text] [Related]
17. Investigation into the Biological Impact of Block Size on Cathepsin S-Degradable HPMA Copolymers.
Fan W; Zhang W; Jia Y; Brusnahan SK; Garrison JC
Mol Pharm; 2017 May; 14(5):1405-1417. PubMed ID: 28263073
[TBL] [Abstract][Full Text] [Related]
18. Targeting prostate carcinoma by G3-C12 peptide conjugated N-(2-hydroxypropyl)methacrylamide copolymers.
Yang Y; Li L; Zhou Z; Yang Q; Liu C; Huang Y
Mol Pharm; 2014 Oct; 11(10):3251-60. PubMed ID: 24955652
[TBL] [Abstract][Full Text] [Related]
19. Semitelechelic HPMA copolymers functionalized with triphenylphosphonium as drug carriers for membrane transduction and mitochondrial localization.
Callahan J; Kopecek J
Biomacromolecules; 2006 Aug; 7(8):2347-56. PubMed ID: 16903681
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin S-cleavable, multi-block HPMA copolymers for improved SPECT/CT imaging of pancreatic cancer.
Fan W; Shi W; Zhang W; Jia Y; Zhou Z; Brusnahan SK; Garrison JC
Biomaterials; 2016 Oct; 103():101-115. PubMed ID: 27372424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
